Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 2012-03-28 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-GERMAIN-LAVAL (42260), Loire
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE SAINT GERMAIN LAVAL : revenue, balance sheet and financial ratios
PHARMACIE DE SAINT GERMAIN LAVAL is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-GERMAIN-LAVAL (42260),
this company of category PME
shows in 2025 a net income positive of 267 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE SAINT GERMAIN LAVAL (SIREN 750869836)
Indicator
2025
2024
2023
2022
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
266 971 €
285 990 €
239 326 €
386 675 €
167 025 €
285 924 €
291 591 €
298 893 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE SAINT GERMAIN LAVAL generates positive net income of 267 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 299 k€ -> 267 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
266 971 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 67%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
66.835%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
49.439%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE SAINT GERMAIN LAVAL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2022
2023
2024
2025
Debt ratio
108.044
83.401
57.59
253.963
151.187
114.867
86.797
66.835
Financial autonomy
42.052
46.739
55.683
24.026
32.569
38.695
42.859
49.439
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
66.832025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average-6 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE SAINT GERMAI... (66.83) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
49.44%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Average+7 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE SAINT GERMAI... (49.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 197.60. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
197.597
Liquidity indicators evolution PHARMACIE DE SAINT GERMAIN LAVAL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2022
2023
2024
2025
Liquidity ratio
168.713
161.218
202.759
198.971
167.793
172.616
181.025
197.597
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
197.62025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Good+13 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE SAINT GERMAI... (197.60) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DE SAINT GERMAIN LAVAL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE SAINT GERMAIN LAVAL is estimated at
4 240 866 €
(range 2 877 871€ - 6 654 502€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2877k€4240k€6654k€
4 240 866 €Range: 2 877 871€ - 6 654 502€
NAF 5 année 2025
Valuation method used
Net Income Multiple
266 971 €
×
15.9x
=4 240 866 €
Range: 2 877 872€ - 6 654 503€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE SAINT GERMAIN LAVAL with other companies in the same sector:
Frequently asked questions about PHARMACIE DE SAINT GERMAIN LAVAL
What is the revenue of PHARMACIE DE SAINT GERMAIN LAVAL ?
The revenue of PHARMACIE DE SAINT GERMAIN LAVAL is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE SAINT GERMAIN LAVAL profitable?
Yes, PHARMACIE DE SAINT GERMAIN LAVAL generated a net profit of 267 k€ in 2025.
Where is the headquarters of PHARMACIE DE SAINT GERMAIN LAVAL ?
The headquarters of PHARMACIE DE SAINT GERMAIN LAVAL is located in SAINT-GERMAIN-LAVAL (42260), in the department Loire.
Where to find the tax return of PHARMACIE DE SAINT GERMAIN LAVAL ?
The tax return of PHARMACIE DE SAINT GERMAIN LAVAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE SAINT GERMAIN LAVAL operate?
PHARMACIE DE SAINT GERMAIN LAVAL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart